Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2017

Mar 29, 2017

30722_dirs_2017-03-29_ef4d8a07-16b1-4ce9-8d5b-3ba0e53fc331.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2017-03-27

Reporting Person: Dreier Ashley (Executive VP, CTO and CIO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-27 Common Stock A 5652 Acquired 5652 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-27 Stock Option (right to buy) $14 A 2000 Acquired 2024-07-30 Common Stock (2000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $1.50 2023-05-09 Common Stock (62500) 62500 Direct
Stock Option (right to buy) $1.50 2023-05-09 Common Stock (100000) 100000 Direct
Stock Option (right to buy) $24.36 2026-03-23 Common Stock (65000) 65000 Direct

Footnotes

F1: On June 30, 2014, the reporting person was granted an option to purchase 10,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2017 were met, resulting in the vesting of the option as to 2,000 shares.

F2: The option is immediately exercisable.

F3: The option is immediately exercisable as to 37,500 shares. The option becomes exercisable as to the remaining 25,000 shares on May 9, 2017.

F4: The option is immediately exercisable as to 16,250 shares. The option becomes exercisable as to the remaining 48,750 shares in three equal installments on March 23, 2018, 2019 and 2020.